nb_cid nb_clickOther -tt-nb this.style.behavior='url(#default#homepage)';this.setHomePage('http://www.aol.com/?mtmhp=acm50ieupgradebanner_112313 network-banner-empty upgradeBanner
14
Search AOL Mail
AOL Mail
Menu
| Weather Weather
300

SearchResults

1 - 12 out of12890 results
  • Popular Cholesterol Drug Now Proven to Hav...(01:47)
  • The cholesterol-reducing drug Zetia, made by Merck & Co., has just been proven effective for high-risk heart disease patients in a multiyear study.
  • Date: November 18, 2014
  • Source: Newsy
  • Cholesterol Drug Recalled(00:31)
  • Merck & Co. is recalling a cholesterol drug due to packaging defects.
  • Date: January 15, 2014
  • Source: FOXCT
  • 'Good Cholesterol' Drugs May Not Be Doing ...(04:01)
  • A recent clinical trial showing the B vitamin niacin didn't reduce heart-health risks compared with standard treatment has doctors wondering why they'...
  • Date: January 07, 2013
  • Source: WSJLive
  • Lice Are Becoming Resistant To Popular Dru...(01:10)
  • More and more head lice are becoming resistant to over-the-counter drug treatments that have been used to kill them. After repeated exposure to the ac...
  • Date: October 20, 2014
  • Source: GeoBeats
  • Biotech Leads the Way as Stocks Move Highe...(02:56)
  • Several positive headlines for various drug companies combined to push the biotech sector higher and bring the other indices along with it. Keith Blis...
  • Date: April 01, 2014
  • Source: The Street
  • How Obamacare Will Help Drug Treatment(01:53)
  • Mark Kleiman, Professor of Public Policy at UCLA, joins HuffPost Live to discuss how the implementation of Obamacare will actually help those seeking ...
  • Date: October 11, 2013
  • Source: HuffPost Live Highlights
  • Biotech's Next Big Thing: Aegerion(01:59)
  • Aegerion and its cholesterol drug will be biotech's big thing in the coming week, says Adam Feuerstein, Sr. Columnist for TheStreet.
  • Date: July 28, 2013
  • Source: The Street
  • Regeneron Shares Trend Higher on Cholester...(00:47)
  • Shares of Regeneron and Sanofi are opening the week higher after researchers revealed Sunday an experimental cholesterol-lowering drug nearly halved t...
  • Date: September 02, 2014
  • Source: The Street
  • Regeneron Rises and CVS Health Quits the H...(01:22)
  • Sanofi and Regeneron revealed this week their experimental cholesterol-lowering drug nearly halved the number of heart attacks and strokes in a clinic...
  • Date: September 05, 2014
  • Source: The Street

123456789101112